Back to search

University of Strathclyde

Investigating the function of interleukin-33 (IL-33) in the central nervous system

Abstract

dc:description.abstract

Background and Purpose: The immunomodulatory cytokine interleukin-33 (IL-33) is a member of the IL-1 cytokine family. Its high level of expression in the central nervous system (CNS) suggests it is likely to play an important role in CNS function. Current research evidence indicates it is involved in the development of several neurological autoimmune diseases, including multiple sclerosis (MS).However, the function of IL-33 in CNS homeostasis under healthy physiological conditions is yet to be clarified. This study therefore aims to further understand the exact function and the underlying mechanism of IL-33 in the CNS through investigating: 1) the regional expression of IL-33 and its receptor ST2 in brain tissues of nai?ve(healthy) and diseased mice; to compare the expression of IL-33 and ST2 receptors in CNS under healthy and diseased condition and 2) the expression of IL-33 and ST2 in the hippocampal culture cells and the function of IL-33 in the brain under healthy conditions. Experimental Methods: C57BL/6 mice were immunised with myelin oligodendrocyte glycoprotein (MOG) ????? peptide to induce experimental autoimmune encephalomyelitis (EAE) and the controls received PBS injection. Clinical scores were recorded daily. Mice were sacrificed on day 26 and CNS tissues were harvested. Immunohistochemical staining was used to study the expression of IL-33 and ST2 in the brain preparations. To identify further the phenotype of the CNS cells expressing IL-33 and ST2 receptors, primary hippocampal cultures were used. IL-33 and ST2 receptor were identified through dual immunohistochemical staining. In addition, the whole cell patch clamp technique was used to determine whether IL-33 modulates synaptic function. Key Result: Data revealed that the expression level of IL-33 was elevated in the hippocampus, midbrain, hypothalamus and cerebellum of the brain tissue of EAE mice compared to nai?ve mice. In contrast, ST2 expression was high in nai?ve mice when compared to EAE mice. However, an unusual cluster of ST2 expression was identified in the EAE brain which was absent in the nai?ve brain. ST2 was also expressed by both astrocytes and neurons of the primary hippocampal culture. Finally, despite the expression of ST2 by the CNS cells in primary hippocampal cultures, its activation with recombinant IL-33 had no effect on neuronal excitability or synaptic activity. Conclusion: These findings show that the IL-33 and its receptor ST2 are highly expressed in CNS under normal and disease conditions with the ST2 receptor being expressed by both astrocytes and neurons of the CNS. However, our study here shows that IL-33 does not seem to modulate neuronal activity and thus further studies are required to determine the exact role of IL-33 under pathological conditions.

Degree

thesis:*
Name dc:type.qualificationname
mres
Level dc:type.qualificationlevel
masters-pg
Grantor dc:publisher.institution
University of Strathclyde
Year dc:date.issued
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hridi, Shehla Unaiza

Rights

Identifiers

dc:identifier.*
Identifier
T13956

Chain of custody

source
Harvested from
University of Strathclyde
Base URL
stax.strath.ac.uk/catalog/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Hridi, Shehla Unaiza. Investigating the function of interleukin-33 (IL-33) in the central nervous system. masters-pg thesis, University of Strathclyde, 2015. https://stax.strath.ac.uk/concern/theses/3j3332278